feed,title,long_url,short_url
Benzinga,KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder,https://benzinga.com/general/biotech/22/01/25129348/kempharm-to-develop-kp1077-as-lead-sdx-candidate-for-chronic-sleep-disorder,https://bit.ly/3FKBieW
